D-serine reuptake inhibitors (Memory)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameD-serine reuptake inhibitors (Memory)
Drug Alias NameNMDA modulators (Memory)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSchizophreniaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemory Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemory Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsSchizophreniaAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A